Superstring Capital Management as of Sept. 30, 2024
Portfolio Holdings for Superstring Capital Management
Superstring Capital Management holds 27 positions in its portfolio as reported in the September 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Zai Lab Adr Call Option (ZLAB) | 15.4 | $18M | 727k | 24.14 | |
| Cytokinetics Com New (CYTK) | 10.0 | $11M | 216k | 52.80 | |
| Terns Pharmaceuticals (TERN) | 9.8 | $11M | 1.3M | 8.34 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 8.7 | $10M | 227k | 43.89 | |
| Oric Pharmaceuticals (ORIC) | 8.5 | $9.7M | 950k | 10.25 | |
| Instil Bio Com New (TIL) | 6.3 | $7.2M | 108k | 67.32 | |
| Novocure Ord Shs (NVCR) | 5.4 | $6.1M | 393k | 15.63 | |
| Bridgebio Pharma (BBIO) | 5.1 | $5.8M | 227k | 25.46 | |
| Fate Therapeutics (FATE) | 4.5 | $5.1M | 1.5M | 3.50 | |
| Capricor Therapeutics Com New (CAPR) | 4.5 | $5.1M | 337k | 15.21 | |
| Tango Therapeutics (TNGX) | 4.0 | $4.6M | 599k | 7.70 | |
| 89bio (ETNB) | 3.9 | $4.4M | 595k | 7.40 | |
| Nkarta (NKTX) | 2.9 | $3.3M | 740k | 4.52 | |
| Legend Biotech Corp Sponsored Ads (LEGN) | 2.6 | $2.9M | 61k | 48.73 | |
| Zenas Biopharma (ZBIO) | 1.7 | $1.9M | 112k | 16.92 | |
| Allogene Therapeutics (ALLO) | 1.2 | $1.3M | 478k | 2.80 | |
| Spyre Therapeutics Com New (SYRE) | 1.0 | $1.1M | 37k | 29.41 | |
| Savara (SVRA) | 0.7 | $848k | 200k | 4.24 | |
| Biomea Fusion (BMEA) | 0.7 | $844k | 84k | 10.10 | |
| Tourmaline Bio (TRML) | 0.7 | $748k | 29k | 25.71 | |
| Zura Bio Class A Ord Shs (ZURA) | 0.6 | $636k | 157k | 4.06 | |
| Cabaletta Bio (CABA) | 0.5 | $622k | 132k | 4.72 | |
| Corbus Pharmaceuticals Hldgs Com New (CRBP) | 0.5 | $524k | 25k | 20.63 | |
| Immunovant (IMVT) | 0.3 | $355k | 12k | 28.51 | |
| Cullinan Oncology (CGEM) | 0.3 | $349k | 21k | 16.74 | |
| Lakeshore Biopharma Ordinary Shares | 0.2 | $212k | 308k | 0.69 | |
| Eliem Therapeutics (CLYM) | 0.2 | $172k | 34k | 5.09 |
